CN102215835A - 一种医药产品及其治疗领域 - Google Patents

一种医药产品及其治疗领域 Download PDF

Info

Publication number
CN102215835A
CN102215835A CN2009801365433A CN200980136543A CN102215835A CN 102215835 A CN102215835 A CN 102215835A CN 2009801365433 A CN2009801365433 A CN 2009801365433A CN 200980136543 A CN200980136543 A CN 200980136543A CN 102215835 A CN102215835 A CN 102215835A
Authority
CN
China
Prior art keywords
milligrams
ibuprofen
acetaminophen
severe
medicament mixed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2009801365433A
Other languages
English (en)
Chinese (zh)
Inventor
哈特利·坎贝尔·阿特金森
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AFT Pharmaceuticals Ltd
Original Assignee
AFT Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42106693&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CN102215835(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by AFT Pharmaceuticals Ltd filed Critical AFT Pharmaceuticals Ltd
Publication of CN102215835A publication Critical patent/CN102215835A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
CN2009801365433A 2008-10-14 2009-10-12 一种医药产品及其治疗领域 Pending CN102215835A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
NZ56961208 2008-10-14
NZ569612 2008-10-14
PCT/NZ2009/000220 WO2010044681A1 (en) 2008-10-14 2009-10-12 A medicinal product and treatment

Publications (1)

Publication Number Publication Date
CN102215835A true CN102215835A (zh) 2011-10-12

Family

ID=42106693

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2009801365433A Pending CN102215835A (zh) 2008-10-14 2009-10-12 一种医药产品及其治疗领域

Country Status (29)

Country Link
US (1) US20110166234A1 (enExample)
EP (1) EP2341900B1 (enExample)
JP (1) JP2012505830A (enExample)
KR (1) KR20110112279A (enExample)
CN (1) CN102215835A (enExample)
AU (1) AU2009304002B9 (enExample)
BR (1) BRPI0914086A2 (enExample)
CA (1) CA2735834C (enExample)
CH (1) CH702339B1 (enExample)
CL (1) CL2011000678A1 (enExample)
CO (1) CO6341553A2 (enExample)
CY (1) CY1122198T1 (enExample)
DK (1) DK2341900T3 (enExample)
ES (1) ES2725151T3 (enExample)
GB (1) GB2476418B (enExample)
HR (1) HRP20190891T1 (enExample)
HU (1) HUE043063T2 (enExample)
LT (1) LT2341900T (enExample)
MA (1) MA32635B1 (enExample)
MX (1) MX340662B (enExample)
MY (1) MY153932A (enExample)
NZ (1) NZ591496A (enExample)
PL (1) PL2341900T3 (enExample)
PT (1) PT2341900T (enExample)
RU (1) RU2487707C2 (enExample)
SI (1) SI2341900T1 (enExample)
TR (2) TR201102810T2 (enExample)
WO (1) WO2010044681A1 (enExample)
ZA (1) ZA201101752B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2431346C (en) 2004-07-07 2010-02-17 Aft Pharmaceuticals Ltd A combination composition comprising paracetamol and ibuprofen
PT2635269T (pt) 2010-11-04 2019-09-04 Aft Pharmaceuticals Ltd Composição de combinação
WO2016008546A1 (en) 2014-07-18 2016-01-21 Everbright Pharmaceuticals S.A.R.L. Aqueous formulation comprising paracetamol and ibuprofen
WO2018192664A1 (en) 2017-04-20 2018-10-25 Hyloris Developments Sa METHOD FOR PREPARING A COMPOSITION WITH A LOW DISSOLVED OXYGEN CONTENT, COMPRISING ACETAMINOPHEN, AND OPTIONALLY ONE OR MORE NSAIDs, AND A COMPOSITION OBTAINED THEREOF
CA3236068A1 (en) 2017-07-10 2019-01-17 Gel Cap Technologies, LLC Dual release dosage form capsule and methods, devices and systems for making same
US11197830B2 (en) 2019-02-27 2021-12-14 Aft Pharmaceuticals Limited Pharmaceutical composition containing acetaminophen and ibuprofen
WO2023281089A2 (en) 2021-07-08 2023-01-12 Krka, D.D., Novo Mesto Pharmaceutical composition comprising naproxen and paracetamol

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0109281A1 (en) * 1982-11-15 1984-05-23 The Upjohn Company Compositions comprising flurbiprofen or ibuprofen
ZA837556B (en) * 1982-11-15 1984-06-27 Upjohn Co Acetominophen and ibuprofen/flurbiprofen
AU605538B2 (en) * 1988-01-19 1991-01-17 Adcock Ingram Limited Pharmaceutical unit
CA1336687C (en) * 1989-08-23 1995-08-15 Thomas M. Tencza Process for preparing tablets containing ibuprofen, apap and caffeine, the products of this process and the use of such products
GB2431346C (en) * 2004-07-07 2010-02-17 Aft Pharmaceuticals Ltd A combination composition comprising paracetamol and ibuprofen
GB0519350D0 (en) * 2005-09-22 2005-11-02 Boots Healthcare Int Ltd Therapeutic agents
US20090264530A1 (en) * 2008-04-16 2009-10-22 Nickell Robert P Combined nsaid and acetaminophen formulation and method

Also Published As

Publication number Publication date
TR201102810T2 (tr) 2011-05-23
KR20110112279A (ko) 2011-10-12
EP2341900A4 (en) 2012-02-29
ES2725151T3 (es) 2019-09-19
HUE043063T2 (hu) 2019-07-29
ZA201101752B (en) 2012-02-29
RU2011111792A (ru) 2012-11-27
PL2341900T3 (pl) 2019-08-30
AU2009304002A1 (en) 2010-04-22
PT2341900T (pt) 2019-05-14
TR201906742T4 (tr) 2019-05-21
CO6341553A2 (es) 2011-11-21
JP2012505830A (ja) 2012-03-08
AU2009304002B2 (en) 2013-04-18
SI2341900T1 (sl) 2019-06-28
GB2476418B (en) 2013-04-24
NZ591496A (en) 2012-12-21
MX340662B (es) 2016-07-20
HRP20190891T1 (hr) 2019-07-12
EP2341900B1 (en) 2019-02-20
MY153932A (en) 2015-04-15
CY1122198T1 (el) 2020-11-25
CA2735834C (en) 2017-05-16
CA2735834A1 (en) 2010-04-22
LT2341900T (lt) 2019-04-10
AU2009304002B9 (en) 2014-06-26
US20110166234A1 (en) 2011-07-07
WO2010044681A1 (en) 2010-04-22
CH702339B1 (de) 2016-06-15
MX2011003928A (es) 2011-08-12
GB201105249D0 (en) 2011-05-11
DK2341900T3 (da) 2019-05-20
BRPI0914086A2 (pt) 2020-01-21
MA32635B1 (fr) 2011-09-01
RU2487707C2 (ru) 2013-07-20
CL2011000678A1 (es) 2011-09-23
GB2476418A (en) 2011-06-22
EP2341900A1 (en) 2011-07-13

Similar Documents

Publication Publication Date Title
CN102215835A (zh) 一种医药产品及其治疗领域
JP2007302657A (ja) 痙症の兆候および症候の緩和方法
US20100226972A1 (en) Transdermal pain gel
Lozada et al. A double-blind, randomized, saline-controlled study of the efficacy and safety of co-administered intra-articular injections of Tr14 and Ze14 for treatment of painful osteoarthritis of the knee: The MOZArT trial
Distler et al. Evidence-based practice: review of clinical evidence on the efficacy of glucosamine and chondroitin in the treatment of osteoarthritis
EP1677806B1 (en) Methods for treating acute and overuse sprain and strain using hyaluronic acid
Gourlay et al. A controlled study of a serotonin reuptake blocker, zimelidine, in the treatment of chronic pain
Hielm-Björkman et al. Evaluating complementary therapies for canine osteoarthritis—Part II: A homeopathic combination preparation (zeel®)
Hatefi et al. Comparing the effect of golghand and psyllium on constipation among the elderly: A randomized clinical trial
US20140037718A1 (en) Transdermal pain gel
CN102228466A (zh) 硫酸软骨素氨糖片
CN104906501A (zh) 治疗银屑病的中药组分组合物
CA2840521C (en) Pharmaceutical composition for treating premature ejaculation and method for treating premature ejaculation
JP2014530249A5 (enExample)
US20140057000A1 (en) Prevention or treatment of painful polyneuropathies by administration of an aluminosilicate
Zhang et al. Preparation and pre-clinical characterization of sustainedrelease ketoprofen implants for the management of pain and inflammation in osteoarthritis
Davis Managing painful conditions in the pharmacy
Sanchez et al. Fellows research article: use of scrambler therapy to treat small fiber neuropathy
CN103315989B (zh) 一种药物组合物
UA136611U (uk) Меновазин вішфа
Horváth et al. The effects of Koloppeloid on knee oateoarthritis in day hospital care: a randomized, controlled, single-blind, follow-up pilot study
Kamhawy et al. Dexmedetomidine as an adjuvant to bupivacaine on combined posterior lumbar plexus and sciatic nerve blocks, is it effective?
CN103301124B (zh) 一种治疗癫痫的药物组合物
Harnphadungkit et al. Efficacy of 0.0125% Capsaicin Patch at Acupuncture Point for Pain Relief in Knee Osteoarthritis: A Randomized Controlled Trial
Satam et al. Clinical study to establish efficacy and safety of Contodol gel as topical pain relieving agent

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20111012